12/28/2015 - 3:37pm

Food and Drug Administration approved the company's famotidine tablets to treat gastroesophageal reflux diesease and active duodenal ulcer.

12/23/2015 - 2:01pm

The Food and Drug Administration on Tuesday announced that it approved AstraZeneca's Zurampic (lesinurad) to treat high levels of uric acid in the blood (hyperuricemia) associated with gout, when combined with a xanthine oxidase inhibitor.

12/23/2015 - 12:37pm

The Food and Drug Administration on Monday approved Actelion Pharmaceutivals' Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension.

12/17/2015 - 1:37pm
The bill, of which there is a version in the Senate and House of Representatives, looks to make it possible for Medicare beneficiaries to use the pharmacy of their choice in a medically underserved area if it is willing to accept Medicare’s contract terms. 
12/17/2015 - 11:15am

The percent of teens abuse of over-the-counter cough medicine containing dextromethorphan to get high remains at 3%, according to the 2015 Monitoring the Future survey.

12/14/2015 - 12:55pm

The dietary supplement industry stands in support of FDA taking enforcement action against misbranded and adulterated products. 

12/10/2015 - 2:27pm

As the Senate investigates the impact of the rising costs of generics, organizations like the National Community Pharmacists Association are weighing in on the debate. The Generic Pharmaceutical Association commented Wednesday on the hearings and what proposed changes mean for the industry.

12/10/2015 - 12:35pm

Newport Trial Group, a California law firm with a reputation for filing class action suits against dietary supplement companies, is being sued for "malicious prosecution and violations of federal racketeering laws" and for paying individuals to pose as injured parties, according to a report Wednesday from Nutra Ingredients USA. "On information and belief, defendants NTG have unlawfully obtained more than $300 million through their lawsuits, much of which can be linked to NTG's scheme to fabricate lawsuits identified in this complaint," the lawsuit reads. (Nutra Ingredients USA)

 

 

 

12/10/2015 - 11:46am

Raymond Kerins, Jr., who joined Bayer in 2013 after serving in senior executive positions at Pfizer and Merck, is a veteran communications and government relations professional.